RXRX — Recursion Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.23bn
- $1.70bn
- $74.68m
Brief: Recursion Pharmaceuticals Inc Files For Class A Common Stock Offering Of Up To $200 Million - SEC Filing
Brief: Recursion Appoints Robert Hershberg As New Chair Of The Board
Live Markets: Healthcare to swim along as AI rally broadens
U.S. STOCKS ON THE MOVE-Annexon, MKS Instruments, Robinhood
Recursion Pharma gains on completing Nvidia-backed supercomputer BioHive-2
U.S. STOCKS ON THE MOVE-GameStop, AC Immune , Fulcrum Therapeutics
Recursion Pharma gains on completing Nvidia-backed supercomputer BioHive-2
Recursion Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary
Brief: Recursion Pharmaceuticals Q1 Net Income USD -91.4 Million
Recursion Pharmaceuticals Inc expected to post a loss of 42 cents a share - Earnings Preview
Recursion Pharmaceuticals Inc expected to post a loss of 42 cents a share - Earnings Preview
Recursion Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Recursion Pharmaceuticals Inc expected to post a loss of 45 cents a share - Earnings Preview
Super Micro, Arm Holdings rally after AI-darling Nvidia's report
Super Micro, most AI-related stocks drop ahead of Nvidia report
Super Micro, other AI-related stocks fall ahead of Nvidia report
AI firms rise after Nvidia discloses stake
Smaller AI firms surge after chip giant Nvidia discloses stake (updated)
Arm, SoundHound AI shares jump as Nvidia builds stake